Although the association of high-volume centres with superior outcomes has been established in numerous countries for numerous cancer types, a new study has confirmed this relationship in England in hospitals treating patients with non-small-cell lung cancer (NSCLC). Data from 12,862 patients who underwent surgical resection for their tumours between 2004 and 2008 were analysed, from a total pool of >134,000 patients with NSCLC. Hospitals performing >150 resections per year had higher rates of survival than those performing <70 (hazard ratio [HR] 0.78, 95% CI 0.67–0.90). Furthermore, high-volume centres achieved these superior results despite having patients who were older, had lower socioeconomic status and more comorbidities than low-volume centres.